Health Canada — Medical Devices · Canada · 2024-12-04 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: In remote circumstances, if a sample containing high cardiac troponin (CTNI) >55,000 pg/ml is tested using an access assay other than Access hsTnI, CTNI carryover may occur if the next test performed, using the same probe on that instrument, is Access hsTnI on a different sample. Recall start date: November 18, 2024
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.